Interleukin-2 inducible T-cell kinase: a potential prognostic biomarker and tumor microenvironment remodeling indicator for hepatocellular carcinoma

por Pan, Binhua, Yang, Modan, Wei, Xuyong, Li, Wangyao, Wang, Kun, Yang, Mengfan, Lu, Di, Wang, Rui, Cen, Beini, Xu, Xiao
Publicado 2021

ATRA sensitized the response of hepatocellular carcinoma to Sorafenib by downregulation of p21-activated kinase 1

por Wang, Kai, Qiu, Xun, Zhang, Zhensheng, Xu, Hanzhi, Tan, Yawen, Su, Renyi, Gao, Fengqiang, Zhuo, Jianyong, Li, Wangyao, Lian, Zhengxing, He, Hong, Xu, Xiao
Publicado 2023

Proteomics‐based identification of the role of osteosarcoma amplified‐9 in hepatocellular carcinoma recurrence

por Wei, Xuyong, Yang, Mengfan, Pan, Binhua, Zhang, Xiaobing, Lin, Hanchao, Li, Wangyao, Shu, Wenzhi, Wang, Kun, Khan, Abdul Rehman, Zhang, Xuanyu, Cen, Beini, Xu, Xiao
Publicado 2022